RESULTS: Based on the PET/CT results, 17 patients were misdiagnosed (9 FN and 8 FP). The sensitivity, specificity, accuracy and negative and positive predictive values for N1/N2 were 50.0, 94.5, 84.0, 93.0 and 58.3%, respectively, whereas those for N2 were 57.8, 90.3, 84.8, 90.3 and 61.1%, respectively. FP findings more frequently occurred in cases with elevated white blood cell (WBC) count (P = 0.015) and smokers (P = 0.04). In the FN group, the maximum standardized uptake value for the primary tumour was lower than that in the truepositive (TP) group (P = 0.01). The short-axis sizes of 71 LNs differently diagnosed by PET/CT and histopathology findings were significantly smaller in the FN group than the TP group (P < 0.001), whereas there was no difference between TP and FP. As for FN LNs in the TP group, there was no significant difference.
INTRODUCTION
It is necessary to assess lymph node (LN) metastasis when treating lung cancer. Although computed tomography (CT) is the standard procedure, it is insufficient because of a lack of sensitivity and specificity [1] . For accurate N staging, it is better to obtain a pathological diagnosis of LNs that appear suspicious in chest CT findings using biopsy along with mediastinoscopy or endobronchial ultrasonography findings, though those procedures are invasive. As for non-invasive methods, positron emission tomography with 2-[
18 F] fluoro-2-deoxy-D-glucose as a tracer in combination with CT (FDG-PET/CT) has been recently used for the diagnosis of LN metastasis. FDG-PET provides quantitative and qualitative information that leads to reliable diagnostic testing for mediastinal LN metastasis. However, few reports have investigated the cause of false-positive (FP) and false-negative (FN) results [2, 3] , even though the differences between histopathological diagnosis and PET/CT results are of considerable clinical importance. In the present study, we analyzed the accuracy of FDG-PET for N staging by focusing on clinical features in FP and FN cases.
PATIENTS AND METHODS

Patients
From March 2006 to February 2010, 112 patients (71 men and 41 women; aged 31-86 years, average 65.6 ± 9.7 years old) with lung cancer who underwent preoperative examinations with FDG-PET/CT, followed by radical resection with hilar and mediastinal dissection (in general, ND2a-2 on UICC Ver. 7) to confirm the histopathological diagnosis of LN metastasis at our institution. We retrospectively reviewed their hospital records. The histopathological types were adenocarcinoma in 84, squamous cell carcinoma in 16, large cell carcinoma in 4 and other carcinoma in 8 cases. A lobectomy was performed in 105, bilobectomy in 3, pneumonectomy in 3 and left main bronchus resection and conventional hilar and mediastinal LN dissection with bronchial carcinoid in 1. The clinical stages were 1A in 63, 1B in 24, 2A in 6, 2B in 4 and 3A in 15, whereas the pathological stages were 1A in 42, 1B in 33, 2A in 9, 2B in 10, 3A in 13, 3B in 1 and 4 in 4 ( Table 1 ). The stage was reclassified according to UICC Ver. 7 (2009).
Diagnosis of LN metastasis
In principle, all patients underwent enhanced chest CT as a preoperative examination. The chest radiologist interpreted the CT scans and LNs were considered metastatic if they were ≥1.0 cm diameter in the short axis. FDG-PET/CT was performed using a whole-body scanner. All patients were asked to fast for at least 4 h before the examination, and CT images were obtained 60 min after the injection of FDG (3.7 mBq/kg), followed immediately by emission scans performed with a 40-50-cm field of view. PET and CT images were reconstructed, and at least two nuclear physicians interpreted them for each case. The standardized uptake value (SUV) was calculated using body weight. LNs were diagnosed as metastatic when the maximum SUV value (SUVmax) was >2.5 or short axis was longer than 1 cm on CT.
Statistical analysis
The study cohort was classified into four groups; true positive (TP), true negative (TN), FP and FN, based on the results of preoperative FDG-PET/CT and post-operative histopathological diagnosis of resected LNs. Those findings were used to determine sensitivity, specificity and negative and positive predictive values. Data are expressed as the mean ± SD or as a proportion. Comparisons between two groups were made using a MannWhitney U-test, with a χ 2 test used for categorical variables. Probability values of <0.05 were to be considered significant.
RESULTS
For PET/CT, 17 patients were misclassified (FN = 9, FP = 8; Table 2 ). The sensitivity, specificity, accuracy, negative predictive value and positive predictive value for N1/N2 were 50.0, 94.5, 84.0, 93.0 and 58.3%, respectively, whereas those for N2 were 57.8, 90.3, 84.8, 90.3 and 61.1%, respectively (Table 3 ). In the FP group, only hilar (cases 10 and 11) and carinal (7) LNs showed intense uptake on PET images. LNs in the FP group were found in patients with inflammation caused by white blood cell (WBC) elevation-WBC count was 8820 ± 3320/μl (P = 0.015) and the ratio of patients with elevated WBC was 4/8 (P = 0.018)-and smoking history (P = 0.04; Table 4 ). In the FN group, the SUVmax of the primary tumours, which included no pure GGO or GGO-dominant lesions, was lower than that in the TP group (P = 0.01; Table 5 ). There was a greater number of stations of histopathologically diagnosed metastatic LNs in the TP group (2.7 ± 1.6 stations) when compared with the FN group (1.7 ± 0.9 stations) (P = 0.047; Table 6 ). We considered that there was a tendency to conclude some FN LNs in the TP group. The short-axis measurements of 71 LNs differently diagnosed between PET/CT and histopathology findings were examined retrospectively using CT images, which revealed that the sizes were significantly smaller in the FN group when compared with the TP group (P < 0.001; Fig. 1 ), whereas there was no difference between the TP and FP groups. As for FN LNs in the TP group, there was no significant difference between PET/CT and histopathology findings.
Comment FDG-PET is the primary examination modality used for lung cancer patients to evaluate LNs and distant metastasis. FDG-PET/ CT is considered superior to FDG-PET alone in terms of sensitivity (85-89%) and specificity (84-94%) [4] [5] [6] . However, for the diagnosis of LN metastasis, it is not uncommon to have FP and FN findings. Thus, comprehensive evaluation is needed, with careful consideration of such data as SUVmax in the primary tumour or lung disease, such as emphysema, silicosis and sarcoidosis.
Cases with smoking history or a large tumour tended to have FP findings for LN metastasis in the present study, and we considered the following possible contributing factors. A PET examination is based on the fact that FDG is taken up by cells that have a higher rate of glycolysis, as represented by malignant cells. However, active glucose metabolism is not only specific to malignancy, but it also occurs in a similar manner in immune cells including macrophages and fibroblasts [7, 8] . An increase in the volume of the LN and macrophages contained inside likely cause FP FDG/PET findings [9] . Nomori et al. [10] reported that FP LNs were significantly larger in size than TP LNs, whereas positive LNs shown by PET and smaller than 9 mm were more likely to be TP than FP. If there lung disease is also present, such as tuberculosis, sarcoidosis, emphysema or idiopathic pneumonitis, it is possible that the LNs will be FP on FDG-PET [11] . Some chemicals in cigarette smoke activate macrophages and epithelial cells, which secrete a number of proinflammatory cytokines including IL-8 and LTB4, thus inducing inflammation with glucose metabolism in the LNs of smokers. It is considered that both inflammation related to smoking and tumour necrosis that causes swelling and increased glucose metabolism in LNs result in FDG accumulation.
In the present FN group, the primary tumours showed low levels of FDG accumulation. The most common histopathological type of lung cancer with FN results obtained with PET is welldifferentiated adenocarcinoma, likely because of the low volume of tumour cells and low cell concentration such as in lepidic predominant tumours [12] [13] [14] . However, FN results with FDG-PET may occur from such factors as micrometastasis, inherited characteristics from the primary tumour [15] and limited metastasis foci. The LN axes in CT images were significantly shorter in the FN group when compared with the TP group, with 77% showing an axis length of <7 mm. Although there was a tendency for multiple metastatic LNs in the TP group, not all were found positive in PET findings. The LN size was not significantly different between the FP group and FN cases in the TP group. Nomori et al. [10] reported that LNs with metastatic foci <4 mm were difficult to detect with PET/CT. Thus, we concluded that the reason for FN findings in the TP group was because metastatic LNs have large cancer cell foci, which leads to additional metastasis, though it is small in cases of distant nodal involvement, known as micrometastasis.
In clinical settings, PET/CT is superior for the detection of N2/ N3 [16] when compared with N1 disease. Recently, minimally invasive techniques such as transbronchial needle aspiration under endobronchial ultrasonography have been utilized for suspected N2 cases. Thus, when possible, it might be better to examine negative LNs if a positive finding is obtained with PET/ CT. For all cases, systematic LN dissection is needed for complete resection and accurate diagnosis of the pathological stage.
Accumulation of additional cases is needed, as PET/CT was introduced 4 years ago in our department. Nevertheless, PET/CT is considered to be feasible to detect metastatic LNs, because the positive predictive value for N2 diagnosis was greater than 90%. Each case must be individually reviewed for careful preoperative diagnosis and dissection of LNs suspected of being FP/ FN based on PET/CT findings.
Conclusions
PET/CT revealed a good diagnostic ability to detect metastatic LNs, especially for N2 diagnosis. However, each patient must be carefully evaluated, as there were some limitations in FP and FN cases.
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